Month: August 2021

WILMINGTON, Del., Aug. 03, 2021 (GLOBE NEWSWIRE) — Ashland Global Holdings Inc. (NYSE: ASH) today announced the intention of its indirect, wholly owned subsidiary Ashland LLC to offer $450 million aggregate principal amount of senior notes (the “Notes”). The Notes will be senior unsecured obligations of Ashland LLC. The Notes will initially be guaranteed on an unsecured basis by Ashland Global Holdings Inc. (the “Guarantee”). Ashland intends to use the net proceeds of the offering (after deducting initial purchasers’ discounts and other fees and expenses) to redeem its obligations under its outstanding 4.750 percent senior notes due 2022, and to pay any premiums, penalties, fees and expenses associated therewith (the “Refinancing”), with any remaining net proceeds to be held as cash on the balance sheet and used for general corporate...

— Received European Commission authorization of IMCIVREE for treatment of obesity and control of hunger associated with POMC, PCSK1 and LEPR deficiencies —— Setmelanotide selected for evaluation as a “Highly Specialised Technology” by Great Britain’s National Institute for Health and Care Excellence —— On track to submit sNDA to FDA and MAA Type II amendment to EMA for setmelanotide in BBS and Alström syndromes in 2H 2021 —— Five new Phase 2 and 3 clinical trials planned to initiate in 2H 2021 —— Management to host conference call at 8 a.m. ET — BOSTON, Aug. 03, 2021 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic diseases of obesity, today reported...

OTTAWA, Aug. 03, 2021 (GLOBE NEWSWIRE) — Leonovus Inc., (“Leonovus”, the “Company”) (TSXV: LTV) today provides a business update and announces that it is working on a Fall 2021 launch of a new product to protect companies from ransomware. Ransomware is a vast and growing global problem. The average ransomware payment increased 43 percent to $220,000 in 2021, according to an April 26 report by Coveware.  Leonovus plans to launch a SaaS product to protect private and public organizations data from ransomware this Fall. Much of the ransomware protection product technology is already available from our Smart Filer, Vault and XVault development initiatives. The real-time SaaS solution will protect an organization’s data from both confidential information exposure and the loss of access to ensure business continuity...

Product approval is the first in the world using Company’s proprietary and patented DEXA Technology™ for custom made implants based upon matching patient’s bone density CARLSBAD, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced it had received U.S. Food and Drug Administration (“FDA”) 510(k) Clearance for its DEXA-C, a new line of cervical cages for anterior cervical discectomy with fusion (ACDF) procedures. This approval is the first using Aurora’s patented DEXA technology, which creates a series of implants manufactured with varying densities to match a patient’s bone density and DEXA T-Score....

Solidifies Gilat’s maritime leadership with initial services to top cruise lines and service providers over SES’s O3b mPOWER and geostationary fleetGilat Solidifies Maritime LeadershipGilat’s multi-orbit platform to power top cruise linesPETAH TIKVA, Israel, Aug. 03, 2021 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, announced today that it has been awarded a multi-million-dollar order by SES for its global mobility platform. This agreement solidifies Gilat’s maritime leadership with initial services to top cruise lines and maritime service providers who will be able to access satellite-enabled services delivered by SES’s O3b mPOWER and geostationary fleet through Gilat’s multi-orbit platform. Gilat’s...

SALT LAKE CITY, Aug. 03, 2021 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced financial results for its second quarter ended June 30, 2021 and provided an update on recent business performance and strategic transformation plans.  “This was another solid quarter for Myriad Genetics as we delivered strong revenue growth and grew earnings ahead of our initial expectations, an important step towards demonstrating our ability to achieve our goal of sustainable long-term growth and profitability,” said Paul J. Diaz, president and CEO. “These results reflect the hard work of our teammates, and their dedication to meeting the needs of our patients and provider partners, as we continue to advance our mission to empower every individual with the genetic answers...

Radisson RED Rosebank Artwork.jpgRadisson RED Rosebank – Room.jpgRadisson RED Rosebank – Rooftop pool.jpgJohannesburg gets RED hot with the opening of Africa’s second Radisson RED hotel The cool barometer of Johannesburg’s already vibrant Rosebank district has hit RED hot with the opening of Radisson RED Johannesburg Rosebank. The first Radisson RED hotel in South Africa’s Gauteng province and only the second to hit African soil after the successful opening of its Capetonian counterpart in 2017, this new-build hotel, situated at Oxford Parks, is a vibrant mixed-use area comprising apartments, retailers, restaurants and offices.Located in South Africa’s cosmopolitan financial hub, Johannesburg, the hotel is nestled in one of its trendiest business nodes, the leafy Rosebank,...